Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 36327426

Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non-Small-Cell Lung Cancer: The Phase III POSEIDON Study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2023 Feb 20
First author
Johnson ML

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Transl Lung Cancer Res. 2023 Jul 31;12(7):1643-1648. doi: 10.21037/tlcr-23-200.
    note
    Source null
    related pmid
    37577310
    relationship
    Comment in

Authors and identifiers

  1. name
    Johnson ML
    type
    Author
  2. name
    Cho BC
    type
    Author
  3. name
    Luft A
    type
    Author
  4. name
    Alatorre-Alexander J
    type
    Author
  5. name
    Geater SL
    type
    Author
  6. name
    Laktionov K
    type
    Author
  7. name
    Kim SW
    type
    Author
  8. name
    Ursol G
    type
    Author
  9. name
    Hussein M
    type
    Author
  10. name
    Lim FL
    type
    Author
  11. name
    Yang CT
    type
    Author
  12. name
    Araujo LH
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Johnson ML
    type
    Author
  2. name
    Cho BC
    type
    Author
  3. name
    Luft A
    type
    Author
  4. name
    Alatorre-Alexander J
    type
    Author
  5. name
    Geater SL
    type
    Author
  6. name
    Laktionov K
    type
    Author
  7. name
    Kim SW
    type
    Author
  8. name
    Ursol G
    type
    Author
  9. name
    Hussein M
    type
    Author
  10. name
    Lim FL
    type
    Author
  11. name
    Yang CT
    type
    Author
  12. name
    Araujo LH
    type
    Author
bibliography ids
  1. nci-bib-209070815a390d701fdc8f43
book metadata
content sha256
03919111bee29ec50f126df404f30ed9aa2258b80255b9d923e61f471b438db4
document type
citation
dois
  1. 10.1200/JCO.22.00975
electronic publication date
display
2022 Nov 3
precision
day
year
2022
evidence scope
bibliographic_metadata_only
id
pubmed:36327426
immutable id
pubmed:36327426@03919111bee29ec50f126df404f30ed9aa2258b80255b9d923e61f471b438db4
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
6
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
1213-1227
volume
41
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Transl Lung Cancer Res. 2023 Jul 31;12(7):1643-1648. doi: 10.21037/tlcr-23-200.
    note
    Source null
    related pmid
    37577310
    relationship
    Comment in
outcomes validated
false
pmid
36327426
provenance
batch id
d370e99271168e8a8a13
provider
NCBI PubMed ESummary
record sha256
d7e075cc7b7e45e99c1ed2b473a18d2abe3b38460d0bde7eef585f60c0af9979
response sha256
f65ace3ceb1efa86f3fbab8e01ce265243e7c6b7f13c5f71c357c1f219ad79c4
retrieved at
2026-09-09T23:48:13.005737+00:00
publication date
display
2023 Feb 20
precision
day
year
2023
publication types
  1. Randomized Controlled Trial
  2. Journal Article
  3. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/36327426/
title
Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non-Small-Cell Lung Cancer: The Phase III POSEIDON Study.

Preserved source evidence · Not medical advice